Cargando…

Phase separation as a therapeutic target in tight junction-associated human diseases

Tight junctions (TJs) play an important role in the maintenance of epithelial and endothelial barriers. Zonula occludens (ZO) proteins are scaffolding molecules essential for the formation of TJ complexes, and abnormalities in ZO proteins have been implicated in various TJ-associated human diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shuang, Zhou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608859/
https://www.ncbi.nlm.nih.gov/pubmed/32694756
http://dx.doi.org/10.1038/s41401-020-0470-y
_version_ 1783604917109260288
author Sun, Shuang
Zhou, Jun
author_facet Sun, Shuang
Zhou, Jun
author_sort Sun, Shuang
collection PubMed
description Tight junctions (TJs) play an important role in the maintenance of epithelial and endothelial barriers. Zonula occludens (ZO) proteins are scaffolding molecules essential for the formation of TJ complexes, and abnormalities in ZO proteins have been implicated in various TJ-associated human diseases such as tumor invasion and metastasis, and barrier dysfunction. Recent studies reveal that liquid–liquid phase separation of ZO proteins drives the polymerization of TJ proteins into a continuous belt, which then recruits various proteins to form the TJ complex to regulate selective paracellular permeability and signal transduction. Herein, we describe recent advances on how ZO phase separation contributes to TJ formation and discuss the potential of phase separation as a target for the treatment of TJ-associated diseases.
format Online
Article
Text
id pubmed-7608859
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-76088592020-11-05 Phase separation as a therapeutic target in tight junction-associated human diseases Sun, Shuang Zhou, Jun Acta Pharmacol Sin Review Article Tight junctions (TJs) play an important role in the maintenance of epithelial and endothelial barriers. Zonula occludens (ZO) proteins are scaffolding molecules essential for the formation of TJ complexes, and abnormalities in ZO proteins have been implicated in various TJ-associated human diseases such as tumor invasion and metastasis, and barrier dysfunction. Recent studies reveal that liquid–liquid phase separation of ZO proteins drives the polymerization of TJ proteins into a continuous belt, which then recruits various proteins to form the TJ complex to regulate selective paracellular permeability and signal transduction. Herein, we describe recent advances on how ZO phase separation contributes to TJ formation and discuss the potential of phase separation as a target for the treatment of TJ-associated diseases. Springer Singapore 2020-07-21 2020-10 /pmc/articles/PMC7608859/ /pubmed/32694756 http://dx.doi.org/10.1038/s41401-020-0470-y Text en © CPS and SIMM 2020
spellingShingle Review Article
Sun, Shuang
Zhou, Jun
Phase separation as a therapeutic target in tight junction-associated human diseases
title Phase separation as a therapeutic target in tight junction-associated human diseases
title_full Phase separation as a therapeutic target in tight junction-associated human diseases
title_fullStr Phase separation as a therapeutic target in tight junction-associated human diseases
title_full_unstemmed Phase separation as a therapeutic target in tight junction-associated human diseases
title_short Phase separation as a therapeutic target in tight junction-associated human diseases
title_sort phase separation as a therapeutic target in tight junction-associated human diseases
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608859/
https://www.ncbi.nlm.nih.gov/pubmed/32694756
http://dx.doi.org/10.1038/s41401-020-0470-y
work_keys_str_mv AT sunshuang phaseseparationasatherapeutictargetintightjunctionassociatedhumandiseases
AT zhoujun phaseseparationasatherapeutictargetintightjunctionassociatedhumandiseases